Common Combivent Side Effects


The most commonly reported Combivent side effects (click to view or check a box to report):

Dyspnoea (675)
Off Label Use (489)
Product Quality Issue (418)
Cough (276)
Overdose (147)
Pneumonia (142)
Prescribed Overdose (107)
Dysgeusia (94)
Chest Discomfort (80)
Wheezing (75)
Dizziness (74)
Choking (69)
Chronic Obstructive Pulmonary Disease (67)
Headache (67)
Oropharyngeal Pain (56)
Throat Irritation (53)
Fall (53)
Dysphonia (51)
Pulmonary Congestion (50)
Asthma (45)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Combivent Side Effects Reported to FDA



Combivent Side Effect Report#9999046
Choking
This is a report of a 62-year-old male patient (weight: NA) from US, suffering from the following health symptoms/conditions: chronic obstructive pulmonary disease, who was treated with Combivent (dosage: Strength: 20 Mcg / 100 Mcg; Daily Dose: 80mcg/400mcg, start time: 201307), combined with:
  • Symbicort (2 Puf)
  • Metoprolol (100 Mg)
and developed a serious reaction and side effect(s): Choking after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Combivent treatment in male patients, resulting in Choking side effect.
Combivent Side Effect Report#9997805
Overdose
This report suggests a potential Combivent Overdose side effect(s) that can have serious consequences. A 76-year-old male patient (weight: NA) from US was diagnosed with the following symptoms/conditions: chronic obstructive pulmonary disease and used Combivent (dosage: Strength: 20 Mcg / 100 Mcg) starting 201307. After starting Combivent the patient began experiencing various side effects, including: OverdoseAdditional drugs used concurrently:
  • Musinex
  • Qbar
Although Combivent demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Overdose, may still occur.
Combivent Side Effect Report#9997649
Gastrooesophageal Reflux Disease, Dyspnoea, Off Label Use
This Gastrooesophageal Reflux Disease problem was reported by a consumer or non-health professional from US. A 85-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: pulmonary fibrosis. On
Jan 22, 2014 this consumer started treatment with Combivent (dosage: Strength: 20 Mcg / 100 Mcg; Daily Dose: 80 Mcg/ 400 Mcg). The following drugs were being taken at the same time: NA. When using Combivent, the patient experienced the following unwanted symptoms/side effects: Gastrooesophageal Reflux Disease, Dyspnoea, Off Label UseAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Gastrooesophageal Reflux Disease, may become evident only after a product is in use by the general population.
Combivent Side Effect Report#9997619
Lung Disorder, Overdose
This Lung Disorder side effect was reported by a consumer or non-health professional from US. A male patient (weight:NA) experienced the following symptoms/conditions: chronic obstructive pulmonary disease.The patient was prescribed Combivent (drug dosage: Strength: 18 Mcg / 103 Mcg), which was initiated on 2002. Concurrently used drugs:
  • Musinex
  • Qbar
.After starting to take Combivent the consumer reported adverse symptoms, such as: Lung Disorder, OverdoseThese side effects may potentially be related to Combivent.
Combivent Side Effect Report#9997438
Cough, Retching
This is a report of a 69-year-old male patient (weight: NA) from US, suffering from the following health symptoms/conditions: chronic obstructive pulmonary disease, who was treated with Combivent (dosage: Strength: 20 Mcg / 100 Mcg; Daily Dose: 80 Mcg/ 400 Mcg, start time: 201401), combined with:
  • Proventil
  • Antihypertensive
and developed a serious reaction and side effect(s): Cough, Retching after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Combivent treatment in male patients, resulting in Cough side effect.
Combivent Side Effect Report#9997119
Dyspnoea
This report suggests a potential Combivent Dyspnoea side effect(s) that can have serious consequences. A 88-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: chronic obstructive pulmonary disease and used Combivent (dosage: Strength: 20 Mcg / 100 Mcg;) starting 201401. After starting Combivent the patient began experiencing various side effects, including: DyspnoeaAdditional drugs used concurrently:
  • Symbicort (4 Puf)
  • Prednisone (5 Mg)
Although Combivent demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Dyspnoea, may still occur.
Combivent Side Effect Report#9996064
Large Intestine Perforation, Intestinal Obstruction, Intestinal Obstruction, Hepatic Failure, Pneumonia, Halo Vision, Visual Impairment
This Large Intestine Perforation problem was reported by a consumer or non-health professional from US. A 55-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: bronchitis chronic. On 201304 this consumer started treatment with Combivent (dosage: Dose Per Application: 20 Mcg / 100 Mcg; Daily Dose: 80 Mcg / 400 Mcg). The following drugs were being taken at the same time: NA. When using Combivent, the patient experienced the following unwanted symptoms/side effects: Large Intestine Perforation, Intestinal Obstruction, Intestinal Obstruction, Hepatic Failure, Pneumonia, Halo Vision, Visual ImpairmentThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Large Intestine Perforation, may become evident only after a product is in use by the general population.
Combivent Side Effect Report#9991833
Blood Glucose Increased
This Blood Glucose Increased side effect was reported by a consumer or non-health professional from US. A 59-year-old female patient (weight:NA) experienced the following symptoms/conditions: chronic obstructive pulmonary disease,diabetes mellitus.The patient was prescribed Combivent (drug dosage: Strength: 20 Mcg/100 Mcg; Daily Dose: 160 Mcg/800 Mcg), which was initiated on 201402. Concurrently used drugs:
  • Glyburide/metformin (Strength: 5/500 Mg)
.After starting to take Combivent the consumer reported adverse symptoms, such as: Blood Glucose IncreasedThese side effects may potentially be related to Combivent.
Combivent Side Effect Report#9988135
Cough, Increased Upper Airway Secretion, Rales, Weight Increased
This is a report of a 67-year-old female patient (weight: NA) from US, suffering from the following health symptoms/conditions: chronic obstructive pulmonary disease, who was treated with Combivent (dosage: Strength: 20 Mcg / 100 Mcg; Daily Dose: 80 Mcg / 400 Mcg, start time: 2012), combined with:
  • Symbicort (Formulation: Inhalation Spray, Strength: 160/4.5 Mcg; Daily Dose: 640/18 Mcg)
  • Proair Hfa (Formulation : Inhalation Spray,)
and developed a serious reaction and side effect(s): Cough, Increased Upper Airway Secretion, Rales, Weight Increased after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Combivent treatment in female patients, resulting in Cough side effect.
Combivent Side Effect Report#9987052
Lung Neoplasm Malignant
This report suggests a potential Combivent Lung Neoplasm Malignant side effect(s) that can have serious consequences. A female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: bronchitis chronic,asthma,hypertension,fluid retention,hypersensitivity,blood cholesterol increased and used Combivent (dosage: Strength: 18 Mcg /103 Mcg) starting 1996. After starting Combivent the patient began experiencing various side effects, including: Lung Neoplasm MalignantAdditional drugs used concurrently:
  • Nebulizer (Formulation: Inhalation Aerosol)
  • Hydrochlorothiazide (12.5 Mg)
  • Hydrochlorothiazide
  • Singulair (10 Mg)
  • Simvastatin (20 Mg)
The patient was hospitalized. Although Combivent demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Lung Neoplasm Malignant, may still occur.
Combivent Side Effect Report#9986815
Off Label Use
This Off Label Use problem was reported by a consumer or non-health professional from US. A female patient (weight: NA) was diagnosed with the following symptoms/conditions: sarcoidosis. On NS this consumer started treatment with Combivent (dosage: Strength: 18 Mcg / 103 Mcg). The following drugs were being taken at the same time: NA. When using Combivent, the patient experienced the following unwanted symptoms/side effects: Off Label UseAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Off Label Use, may become evident only after a product is in use by the general population.
Combivent Side Effect Report#9983354
Feeling Jittery, Feeling Jittery, Malaise, Tremor, Off Label Use
This Feeling Jittery side effect was reported by a consumer or non-health professional from US. A 60-year-old female patient (weight:NA) experienced the following symptoms/conditions: cough.The patient was prescribed Combivent (drug dosage: Strength: 20 Mcg / 100 Mcg; Daily Dose: 80 Mcg/ 400 Mcg), which was initiated on 2013. Concurrently used drugs: NA..After starting to take Combivent the consumer reported adverse symptoms, such as: Feeling Jittery, Feeling Jittery, Malaise, Tremor, Off Label UseThese side effects may potentially be related to Combivent.
Combivent Side Effect Report#9983342
Overdose
This is a report of a 70-year-old male patient (weight: NA) from US, suffering from the following health symptoms/conditions: NA, who was treated with Combivent (dosage: Strength: 20 Mcg / 100 Mcg; Daily Dose: 160 Mcg/800 Mcg, start time: 201305), combined with: NA. and developed a serious reaction and side effect(s): Overdose after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Combivent treatment in male patients, resulting in Overdose side effect.
Combivent Side Effect Report#9981177
Deafness, Arthritis, Visual Acuity Reduced
This report suggests a potential Combivent Deafness side effect(s) that can have serious consequences. A female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: chronic obstructive pulmonary disease and used Combivent (dosage: Dose Per Application: 18 Mcg / 103 Mcg) starting NS. After starting Combivent the patient began experiencing various side effects, including: Deafness, Arthritis, Visual Acuity ReducedAdditional drugs used concurrently: NA. Although Combivent demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Deafness, may still occur.
Combivent Side Effect Report#9973551
Choking, Dysphonia
This Choking problem was reported by a consumer or non-health professional from US. A 74-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: chronic obstructive pulmonary disease. On
Feb 14, 2014 this consumer started treatment with Combivent (dosage: Strength: 20 Mcg / 100 Mcg; Daily Dose: 80 Mcg/400 Mcg). The following drugs were being taken at the same time: NA. When using Combivent, the patient experienced the following unwanted symptoms/side effects: Choking, DysphoniaAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Choking, may become evident only after a product is in use by the general population.
Combivent Side Effect Report#9969814
Dyspnoea Exertional, Activities Of Daily Living Impaired
This Dyspnoea Exertional side effect was reported by a consumer or non-health professional from US. A 90-year-old male patient (weight:NA) experienced the following symptoms/conditions: chronic obstructive pulmonary disease.The patient was prescribed Combivent (drug dosage: Dose Per Application : 20 Mcg / 100 Mcg; Daily Dose: 80 Mcg/400 Mcg), which was initiated on
Oct 24, 2013. Concurrently used drugs:
  • Advair (Formulation: Inhalation Aerosol)
  • Lisinopril (20 Mg)
  • Amlodipine (10 Mg)
  • Synthroid
.After starting to take Combivent the consumer reported adverse symptoms, such as: Dyspnoea Exertional, Activities Of Daily Living ImpairedThese side effects may potentially be related to Combivent.
Combivent Side Effect Report#9969493
Off Label Use
This is a report of a 77-year-old female patient (weight: NA) from US, suffering from the following health symptoms/conditions: pneumonia, who was treated with Combivent (dosage: Dose Per Application: 20 Mcg / 100 Mcg; Daily Dose: 80mcg/400mcg, start time:
Feb 21, 2014), combined with: NA. and developed a serious reaction and side effect(s): Off Label Use after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Combivent treatment in female patients, resulting in Off Label Use side effect.
Combivent Side Effect Report#9964449
Pneumonia
This report suggests a potential Combivent Pneumonia side effect(s) that can have serious consequences. A 57-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: chronic obstructive pulmonary disease and used Combivent (dosage: Dose Per Apllication: 20 Mcg / 100 Mcg; Daily Dose: 80 Mcg/ 400 Mcg) starting 2012. After starting Combivent the patient began experiencing various side effects, including: PneumoniaAdditional drugs used concurrently: NA.The patient was hospitalized. Although Combivent demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Pneumonia, may still occur.
Combivent Side Effect Report#9964445
Thrombosis
This Thrombosis problem was reported by a consumer or non-health professional from US. A 58-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: chronic obstructive pulmonary disease,diabetes mellitus. On NS this consumer started treatment with Combivent (dosage: Dose Per Application: 18 Mcg / 103 Mcg; Daily Dose: 144 Mcg/824 Mcg). The following drugs were being taken at the same time:
  • Glyburide/metformin (Dose Per Application: 5/500 Mg)
When using Combivent, the patient experienced the following unwanted symptoms/side effects: ThrombosisThe patient was hospitalized.Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Thrombosis, may become evident only after a product is in use by the general population.
Combivent Side Effect Report#9964440
Lung Infection, Chronic Obstructive Pulmonary Disease
This Lung Infection side effect was reported by a consumer or non-health professional from US. A male patient (weight:NA) experienced the following symptoms/conditions: chronic obstructive pulmonary disease.The patient was prescribed Combivent (drug dosage: Strength: 18 Mcg / 103 Mcg; Daily Dose: 144 Mcg / 824 Mcg), which was initiated on 2012. Concurrently used drugs: NA..After starting to take Combivent the consumer reported adverse symptoms, such as: Lung Infection, Chronic Obstructive Pulmonary DiseaseThese side effects may potentially be related to Combivent. The patient was hospitalized.
Combivent Side Effect Report#9964307
Off Label Use
This is a report of a 67-year-old female patient (weight: NA) from US, suffering from the following health symptoms/conditions: asthma,chronic obstructive pulmonary disease, who was treated with Combivent (dosage: Strength: 20 Mcg / 100 Mcg; Daily Dose: 80 Mcg/ 400 Mcg, start time:
Feb 21, 2014), combined with: NA. and developed a serious reaction and side effect(s): Off Label Use after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Combivent treatment in female patients, resulting in Off Label Use side effect.
Combivent Side Effect Report#9961544
Headache, Throat Tightness
This report suggests a potential Combivent Headache side effect(s) that can have serious consequences. A 84-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: chronic obstructive pulmonary disease and used Combivent (dosage: Strength: 20 Mcg / 100 Mcg; Daily Dose: 80 Mcg/ 400 Mcg) starting
Feb 20, 2014. After starting Combivent the patient began experiencing various side effects, including: Headache, Throat TightnessAdditional drugs used concurrently:
  • Aspirin
Although Combivent demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as Headache, may still occur.
Combivent Side Effect Report#9961446
Choking, Cough
This Choking problem was reported by a consumer or non-health professional from US. A female patient (weight: NA) was diagnosed with the following symptoms/conditions: chronic obstructive pulmonary disease. On 201308 this consumer started treatment with Combivent (dosage: Dose Per Application: 20 Mcg / 100 Mcg; Daily Dose: 80 Mcg/400 Mcg). The following drugs were being taken at the same time: NA. When using Combivent, the patient experienced the following unwanted symptoms/side effects: Choking, CoughAlthough all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as Choking, may become evident only after a product is in use by the general population.
Combivent Side Effect Report#9961170
Off Label Use, Off Label Use
This Off Label Use side effect was reported by a health professional from US. A male patient (weight:NA) experienced the following symptoms/conditions: cystic fibrosis.The patient was prescribed Combivent (drug dosage: Strength: 20 Mcg / 100 Mcg; Daily Dose: 80 Mcg / 400 Mcg), which was initiated on NS. Concurrently used drugs: NA..After starting to take Combivent the consumer reported adverse symptoms, such as: Off Label Use, Off Label UseThese side effects may potentially be related to Combivent.
Combivent Side Effect Report#9954327
Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease, Lung Neoplasm Malignant, Chronic Obstructive Pulmonary Disease, Off Label Use
This is a report of a female patient (weight: NA) from US, suffering from the following health symptoms/conditions: asthma, who was treated with Combivent (dosage: Strength: 18 Mcg / 103 Mcg; Daily Dose: 144 Mcg/824 Mcg, start time: 1996), combined with: NA. and developed a serious reaction and side effect(s): Chronic Obstructive Pulmonary Disease, Chronic Obstructive Pulmonary Disease, Lung Neoplasm Malignant, Chronic Obstructive Pulmonary Disease, Off Label Use after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Combivent treatment in female patients, resulting in Chronic Obstructive Pulmonary Disease side effect. The patient was hospitalized.


1 of 99 


The appearance of Combivent on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.

What are common Combivent Side Effects for Women?

Women Side Effects Reports
Dyspnoea 425
Off Label Use 322
Product Quality Issue 276
Cough 208
Pneumonia 92
Overdose 86
Prescribed Overdose 61
Dizziness 58
Headache 56
Chest Discomfort 54

What are common Combivent Side Effects for Men?

Men Side Effects Reports
Dyspnoea 249
Off Label Use 166
Product Quality Issue 141
Cough 67
Overdose 60
Pneumonia 48
Prescribed Overdose 45
Dysgeusia 40
Wheezing 30
Chest Discomfort 25

Track Your Side Effects

Note Your Observations

It is really important to keep track of your health symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Combivent reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
    FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.

    Discuss Combivent Side Effects

    Did You Have a Combivent Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Combivent for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Combivent Safety Alerts, Active Ingredients, Usage Information

    NDC 0597-0013
    Type HUMAN PRESCRIPTION DRUG
    Proprietary Name Combivent
    Name ipratropium bromide and albuterol sulfate
    Dosage Form AEROSOL, METERED
    Route RESPIRATORY (INHALATION)
    On market since 19970601
    Labeler Boehringer Ingelheim Pharmaceuticals, Inc.
    Active Ingredient(s) ALBUTEROL SULFATE; IPRATROPIUM BROMIDE
    Strength(s) 103; 18
    Unit(s) ug/1; ug/1
    Pharma Class Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC],Anticholinergic [EPC],Cholinergic Ant

    Combivent Dosage, Warnings, Usage.

    Side Effects reported to FDA: 2452

    Combivent safety alerts: No

    Reported deaths: 98

    Reported hospitalizations: 610

    Latest Combivent clinical trials

    privacy policy